Corporate Accountability

Congressional Power Again in Supreme Court’s Sights

By John Gramlich, CQ Roll Call

 

The Supreme Court opened a new term Monday that so far lacks the blockbuster cases that marked its last session, when the justices struck down the heart of two landmark social laws — the 1965 Voting Rights Act and the 1996 Defense of Marriage Act — that received overwhelmingly bipartisan backing in Congress.

 

The court’s new term, however, still provides plenty of opportunities for the justices to either circumscribe or reinforce congressional authority, including in ways that will divide the political parties.

 

 

“This term presents the court with a large number of opportunities to cut back on statutes passed by Congress and limit Congress’ power itself,” said Doug Kendall, president of the progressive Constitutional Accountability Center. “Anyone caring about Congress’ ability to fix national problems should be closely watching what the Supreme Court is up to.”

 

Kendall added that the current political paralysis in Congress — exemplified by the first government shutdown in 17 years — raises the stakes at the Supreme Court.

 

“Historically, Congress has been much more active and aggressive in overturning statutory rulings by the Supreme Court,” he said. “It has, by and large, stopp[ed] overturning Supreme Court rulings, which allows the court to encroach significantly on congressional power.”… 

More from Corporate Accountability

Corporate Accountability
U.S. Court of Appeals for the Third Circuit

Novartis v. Secretary United States Department of Health and Human Services

In Novartis v. Secretary United States Department of Health and Human Services, the United States Court of Appeals for the Third Circuit is considering whether the Inflation Reduction Act’s Medicare drug price negotiation program is...
Corporate Accountability
January 28, 2025

Federal Deposit Insurance as Jarkesy Waiver

Yale Journal on Regulation
An argument lurking just beneath the surface in a pending Fifth Circuit case could stem...
Corporate Accountability
U.S. Court of Appeals for the Second Circuit

Boehringer Ingelheim v. Department of Health and Human Services

In Boehringer Ingelheim v. Department of Health and Human Services, the United States Court of Appeals for the Second Circuit is considering whether the Inflation Reduction Act’s Medicare drug price negotiation program is an unconstitutional...
Corporate Accountability
U.S. Court of Appeals for the Fifth Circuit

Ortega v. Office of the Comptroller of the Currency

In Ortega v. Office of the Comptroller of the Currency, the United States Court of Appeals for the Fifth Circuit is considering a challenge to the Office of the Comptroller of the Currency’s authority to...
Corporate Accountability
U.S. Court of Appeals for the Fifth Circuit

Burgess v. Whang

In Burgess v. Whang, the Fifth Circuit is considering a challenge to the Federal Deposit Insurance Corporation’s authority to issue penalties and other supervisory orders. 
Corporate Accountability
October 23, 2024

The Constitution Doesn’t Entitle Drug Manufacturers to a Sweetheart Deal

Washington
Big Pharma is in federal appeals court making the absurd argument that Medicare shouldn’t be...
By: Nina Henry